This site is intended for healthcare professionals

Positive effect of reltecimod on resolution of organ dysfunction in phase III ACCUTE trial for patients with necrotizing soft tissue infection .- Atox Bio

Read time: 1 mins
Last updated:13th Jul 2020
Published:13th Jul 2020
Condition: Necrotizing Soft Tissue Infection
Type: drug
Register free for full access to